Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of meningococcal A conjugate vaccine versus Mencevax versus Hiberix in toddlers
ISRCTN78147026Phase 2Completed
- Sponsor
- Serum Institute of India
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, single-blind trial of meningococcal A conjugate vaccine, quadrivalent meningococcal vaccine and haemophilus influenzae type b vaccine in meningococcal disease (3 arms), sponsored by Serum Institute of India. Primary endpoint: Seroconversion for anti-meningococcal polysaccharide A antibodies by rSBA. Started Aug 2006; status: completed.
02
Drugs
meningococcal A conjugate vaccinequadrivalent meningococcal vaccinehaemophilus influenzae type b vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on ISRCTN78147026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN78147026.